GSK plc. - Strategy, SWOT and Corporate Finance Report
GSK plc. %li%Strategy, SWOT and Corporate Finance Report
Summary
GSK plc. %li%Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
GSK plc. (GSK or 'the company'), formerly GlaxoSmithKline plc, is a developer, manufacturer, and marketer of vaccines, pharmaceuticals, over-the-counter (OTC) medicines and consumer healthcare products. The company offers medicines for various therapeutic areas, including respiratory, HIV, metabolic, anti-virals, urogenital, central nervous system, immuno-inflammation, cardiovascular, anti-bacterials and dermatology. GSK markets its products under Volibris, FluLaval, Bexsero, Menveo, Polident, Boostrix, Priorix, Otrivin, Theraflu, Aquafresh, and Imitrex brand names. It merchandises and sells these products through pharmacies, hospitals, wholesalers, and physicians worldwide. GSK has a business presence across the Americas, the Middle East, Africa, Australasia, and Europe. The company is headquartered in Brentford, Middlesex, the UK.
Scope
Summary
GSK plc. %li%Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
GSK plc. (GSK or 'the company'), formerly GlaxoSmithKline plc, is a developer, manufacturer, and marketer of vaccines, pharmaceuticals, over-the-counter (OTC) medicines and consumer healthcare products. The company offers medicines for various therapeutic areas, including respiratory, HIV, metabolic, anti-virals, urogenital, central nervous system, immuno-inflammation, cardiovascular, anti-bacterials and dermatology. GSK markets its products under Volibris, FluLaval, Bexsero, Menveo, Polident, Boostrix, Priorix, Otrivin, Theraflu, Aquafresh, and Imitrex brand names. It merchandises and sells these products through pharmacies, hospitals, wholesalers, and physicians worldwide. GSK has a business presence across the Americas, the Middle East, Africa, Australasia, and Europe. The company is headquartered in Brentford, Middlesex, the UK.
Scope
- Detailed information on GSK plc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting GSK plc. in the form of a SWOT analysis
- An in-depth view of the business model of GSK plc. including a breakdown and examination of key business segments
- Intelligence on GSK plc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about GSK plc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of GSK plc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess GSK plc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on GSK plc.'s business structure, strategy and prospects.
Company Snapshot
GSK plc.: Company Overview
GSK plc.: Overview and Key Facts
GSK plc.: Overview
GSK plc.: Key Facts
GSK plc.: Key Employees
GSK plc.: Key Employee Biographies
GSK plc.: Major Products and Services
GSK plc.: Management Statement
GSK plc.: Locations and Subsidiaries
GSK plc.: Key Competitors
GSK plc.: Company Analysis
GSK plc.: Business Description
GSK plc.: SWOT Analysis
GSK plc.: SWOT Overview
GSK plc.: Strengths
GSK plc.: Weaknesses
GSK plc.: Opportunities
GSK plc.: Threats
GSK plc.: Corporate Financial Deals Activity
GSK plc.: Financial Deals Overview
GSK plc.: Targets and Partners
GSK plc.: Top Deals 2019 - 2023YTD*
GSK plc.: Advisors
GSK plc.: Top Legal Advisors
GSK plc.: Top Financial Advisors
GSK plc.: Mergers and Acquisitions
GSK plc.: Corporate Venturing
GSK plc.: Capital Raising
GSK plc.: Partnership
GSK plc.: Divestments
GSK plc.: Recent Developments
GSK plc.: News and Events Summary
GSK plc.: Contracts
GSK plc.: Financial Deals
GSK plc.: Financial Performance
GSK plc.: Grants
GSK plc.: Market Developments
GSK plc.: Research & Development
GSK plc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
LIST OF TABLES
Table 1: GSK plc.: Key Facts
Table 2: GSK plc.: Key Employees
Table 3: GSK plc.: Locations and Subsidiaries
Table 4: GSK plc.: Key Competitors
Table 5: GSK plc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: GSK plc.: M&A Activity by Geography (TTM*)
Table 7: GSK plc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: GSK plc.: M&A Average Deal Size - Value (US$m)
Table 9: GSK plc.: Targets and Partners
Table 10: GSK plc.: Top Deals 2019 - 2023YTD*
Table 11: GSK plc.: Legal Advisor Ranking by Value (US$m)
Table 12: GSK plc.: Financial Advisor Ranking by Value (US$m)
Table 13: GSK plc.: M&A Volume and Value Trend (2019 - YTD*2023)
Table 14: GSK plc.: M&A Activity by Geography (2019 - YTD*2023)
Table 15: GSK plc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 16: GSK plc.: Corporate Venturing by Geography (2019 - YTD*2023)
Table 17: GSK plc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 18: GSK plc.: Capital Raising by Deal Type (2019 - YTD*2023)
Table 19: GSK plc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 20: GSK plc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 21: GSK plc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 22: GSK plc.: Divestments by Geography (2019 - YTD*2023)
Table 23: GSK plc.: News and Events Summary
Table 24: GSK plc.: Contracts
Table 25: GSK plc.: Financial Deals
Table 26: GSK plc.: Financial Performance
Table 27: GSK plc.: Grants
Table 28: GSK plc.: Market Developments
Table 29: GSK plc.: Research & Development
Table 30: GSK plc.: Strategy and Operations
Table 1: GSK plc.: Key Facts
Table 2: GSK plc.: Key Employees
Table 3: GSK plc.: Locations and Subsidiaries
Table 4: GSK plc.: Key Competitors
Table 5: GSK plc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: GSK plc.: M&A Activity by Geography (TTM*)
Table 7: GSK plc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: GSK plc.: M&A Average Deal Size - Value (US$m)
Table 9: GSK plc.: Targets and Partners
Table 10: GSK plc.: Top Deals 2019 - 2023YTD*
Table 11: GSK plc.: Legal Advisor Ranking by Value (US$m)
Table 12: GSK plc.: Financial Advisor Ranking by Value (US$m)
Table 13: GSK plc.: M&A Volume and Value Trend (2019 - YTD*2023)
Table 14: GSK plc.: M&A Activity by Geography (2019 - YTD*2023)
Table 15: GSK plc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 16: GSK plc.: Corporate Venturing by Geography (2019 - YTD*2023)
Table 17: GSK plc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 18: GSK plc.: Capital Raising by Deal Type (2019 - YTD*2023)
Table 19: GSK plc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 20: GSK plc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 21: GSK plc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 22: GSK plc.: Divestments by Geography (2019 - YTD*2023)
Table 23: GSK plc.: News and Events Summary
Table 24: GSK plc.: Contracts
Table 25: GSK plc.: Financial Deals
Table 26: GSK plc.: Financial Performance
Table 27: GSK plc.: Grants
Table 28: GSK plc.: Market Developments
Table 29: GSK plc.: Research & Development
Table 30: GSK plc.: Strategy and Operations
LIST OF FIGURES
Figure 1: GSK plc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: GSK plc.: M&A Activity by Geography (TTM*)
Figure 3: GSK plc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 4: GSK plc.: M&A Average Deal Size - Value (US$m)
Figure 5: GSK plc.: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 6: GSK plc.: M&A Activity by Geography (2019 - YTD*2023)
Figure 7: GSK plc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 8: GSK plc.: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 9: GSK plc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 10: GSK plc.: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 11: GSK plc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 12: GSK plc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 13: GSK plc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Figure 14: GSK plc.: Divestments by Geography (2019 - YTD*2023)
Figure 1: GSK plc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: GSK plc.: M&A Activity by Geography (TTM*)
Figure 3: GSK plc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 4: GSK plc.: M&A Average Deal Size - Value (US$m)
Figure 5: GSK plc.: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 6: GSK plc.: M&A Activity by Geography (2019 - YTD*2023)
Figure 7: GSK plc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 8: GSK plc.: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 9: GSK plc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 10: GSK plc.: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 11: GSK plc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 12: GSK plc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 13: GSK plc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Figure 14: GSK plc.: Divestments by Geography (2019 - YTD*2023)
